Lumos Diagnostics Holdings Limited

A$0.06As of Sun 8 Nov 2026, 12:00 UTC
ASX:LDXHealthcare
Country Australia
PE (Fwd) •••
TSR 5Y CAGR (41.09%)
Div yield —
ROE (34.13%)
Medical Devices
Beta (5Y) 0.51
PE TTM —
TSR TTM (70.73%)
Mkt cap A$58.30M
ROIC (42.11%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0738
23.06%
(62.15%)
Hold 3|5|8|9|8
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
11.50%
15.47%
11.49%
16.89%
Revenue$M
2.855
2.810
2.909
2.912
7.70%
6.00%
4.02%
1.04%
Peers (US$40.04M)
Cap (US$)
PE
43.77M
—
39.44M
—
39.29M
—
Capital
TTM
5Y
10Y
Leveragex
0.776
1.321
1.147
EBIT/Intx
0.305
0.351
0.291
Own earn%
3.84
26.36
30.87
Sh yield%
44.37
41.30
38.82
Owners
Insiders/Inst%
5.47
68.86
Short interest%
5.89
SBC / revenue%
3.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
19–32
$1 testx
0.0
Incr. ROIC%
6